Show Notes
OpenClaw 2.0 just landed, and we’re going straight to the person helping build it. 🦞
This week on The Neuron LIVE, Vincent Koc, Chief Architect of OpenClaw, joins us for a hands-on look at the biggest OpenClaw update yet.
Vincent will demo OpenClaw 2.0, break down what’s new, and show how OpenClaw is evolving from an open-source personal AI assistant into a broader agentic computing platform.
We’ll cover: 🦞 OpenClaw 2.0 and the biggest changes 🖥️ The new OpenClaw experience and easier setup 🤖 Running agents across local machines and cloud workers 📊 Interactive widgets, dashboards, and persistent agent work ⚡ New automations, loops, and approval controls 🧠 Local models, memory, and agent interoperability 🐝 Experimental multi-agent features like Swarm 🔐 Credentials, permissions, and agent security 🔮 Where OpenClaw and personal AI agents go from here
Plus, because this is LIVE, we’ll put your questions directly to Vincent while he walks us through the new release.
Whether you’re curious about OpenClaw, already running your own lobster, or want to see how far personal AI agents have come in 2026, this is one to watch.
Subscribe to The Neuron for practical AI news, analysis, interviews, and demos without the hype.
More from The Neuron: AI Explained
Neurosurgeon-scientists Alex Ksendzovsky and Jon Pomeraniec explain how The Biological Computing Company uses living neurons as a research platform for AI. Their team grows roughly 150,000 cells on a 4,096-electrode array, sends in patterns such as handwritten digits, records how the neurons respond, and models useful computational behaviors in software. They say those neuron-inspired techniques are already helping GPU-based video-generation systems run about 5x faster with roughly 80% lower inference cost, while their longer-term work explores robots, world models, and real-time biological compute.
OpenAI just dropped 20+ announcements at DevDay 2026, so... yeah, we have some things to talk about. 😺
Runway co-founder Anastasis Germanidis explains Solaris, an “interface world model” that generates software frame by frame instead of rendering a traditional interface from HTML and CSS.
OpenAI DevDay 2026 is here, and we’re hosting a watch party to watch the keynote LIVE.
Corey and Grant sit down with Mammoth Biosciences co-founder and CEO Dr. Trevor Martin to explain how CRISPR is moving from a laboratory tool toward one-time medicines.